Creatine supplementation and aging musculoskeletal health

被引:0
作者
Darren G. Candow
Philip D. Chilibeck
Scott C. Forbes
机构
[1] University of Regina,Faculty of Kinesiology and Health Studies
[2] University of Saskatchewan,College of Kinesiology
[3] University of Calgary,Faculty of Medicine
来源
Endocrine | 2014年 / 45卷
关键词
Sarcopenia; Resistance training; Bone health; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
Sarcopenia refers to the progressive loss of muscle mass and muscle function and is a contributing factor for cachexia, bone loss, and frailty. Resistance training produces several physiological adaptations which improve aging musculoskeletal health, such as increased muscle and bone mass and strength. The combination of creatine supplementation and resistance training may further lead to greater physiological benefits. We performed meta-analyses which indicate creatine supplementation combined with resistance training has a positive effect on aging muscle mass and upper body strength compared to resistance training alone. Creatine also shows promise for improving bone mineral density and indices of bone biology. The combination of creatine supplementation and resistance training could be an effective intervention to improve aging musculoskeletal health.
引用
收藏
页码:354 / 361
页数:7
相关论文
共 367 条
  • [1] Cruz-Jentoft AJ(2010)European Working Group on Sarcopenia in Older People.: sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People Age Ageing 39 412-423
  • [2] Baeyens JP(2011)Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia J. Am. Med. Dir. Assoc. 12 249-256
  • [3] Bauer JM(2008)Cachexia: a new definition Clin Nutr. 27 793-799
  • [4] Boirie Y(2005)Sarcopenia and osteoporosis: a hazardous duet J. Endocrinol. Invest. 28 66-68
  • [5] Cederholm T(2013)Frailty in elderly people Lancet 2 752-762
  • [6] Landi F(2004)The healthcare costs of sarcopenia in the United States J. Am. Geriatr. Soc. 52 80-85
  • [7] Martin FC(2012)Exercise and nutritional interventions for improving aging muscle health Endocrine 42 29-38
  • [8] Michel JP(2013)Atrogin-1, MuRF-1, and sarcopenia Endocrine 43 12-21
  • [9] Rolland Y(2013)The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size Exp. Gerontol. 48 492-498
  • [10] Schneider SM(2003)Sarcopenia—consequences, mechanisms, and potential therapies Mech. Ageing Dev. 124 287-299